SCHEMBL4195751

SCHEMBL4195751

O=C(Nc1cc(Cl)ccc1Cl)c1cc[nH]n1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.53
KMT2A Q03164 5/20 0.53
POLB P06746 1/20 0.53
JAK2 O60674 1/20 0.51
JAK1 P23458 1/20 0.51
MAPT P10636 2/20 0.49
HPGD P15428 2/20 0.49
HSD17B10 Q99714 2/20 0.49
HTT P42858 2/20 0.49
TSHR P16473 2/20 0.49
ALDH1A1 P00352 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2C9 P11712 1/20 0.49
ALOX15 P16050 1/20 0.49
CYP2C19 P33261 1/20 0.49
RAB9A P51151 1/20 0.48
TDP1 Q9NUW8 2/20 0.47
MAPK1 P28482 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4198230 0.88 ALOX15 (0.63) MEN1KMT2APOLBHPGDTSHR
SCHEMBL4198299 0.87 KCNMA1 (0.59) MEN1KMT2APOLBMAPTHPGD
SCHEMBL4188965 0.84 MEN1 (0.45) MEN1KMT2APOLBJAK2JAK1
SCHEMBL4199011 0.82 NPC1 (0.53) MEN1KMT2APOLBMAPTHPGD
SCHEMBL4196298 0.82 ALDH1A1 (0.46) MEN1KMT2AMAPTHSD17B10HTT
SCHEMBL4198306 0.79 ALOX15 (0.44) MEN1KMT2AMAPTHPGDHSD17B10
SCHEMBL23246023 0.78 NPC1 (0.53) MEN1KMT2AHPGDHTTALDH1A1
SCHEMBL23246073 0.77 GRM4 (0.57) MEN1KMT2APOLBMAPTHPGD
SCHEMBL4205361 0.77 RAB9A (0.56) MEN1KMT2APOLBMAPTHPGD
SCHEMBL4186735 0.77 ALOX15 (0.65) KMT2ACYP1A2CYP3A4CYP2C9ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090088463-A1 Pyrazoles Useful in the Treatment of Inflammation BIOLIPOX AB (SE) 2009-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090088463-A1 Pyrazoles Useful in the Treatment of Inflammation ALOX15, ALOX5, ALOX15B MEN1 4164/4885KMT2A 4552/4885POLB 2613/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.